News & Analysis on Clinical Trial Services & Contract Research And Development
Mass spectroscopy as an analytical laboratory technique proved it's worth again recently after Cerno Bioscience and Wyeth Pharmaceuticals jointly produced a paper that demonstrates the high mass accuracy that can be achieved using triple quadrupole...
Locus Pharmaceuticals is to initiate Phase I trials of a novel anticancer drug that could prove effective against drug resistant tumours after the small molecule cleared the 30-day review period by the FDA for its Investigational New Drug (IND)...
Outourcing-Pharma focus on: FDA clinical trial initiatives
The US Food and Drug Administration (FDA) has announced a series of new policy and regulatory developments to modernise the way it monitors clinical trials and bioresearch.
Anderson Packaging has bought 12 acres of land next to its existing US headquarters and now plans to build another new facility to expand its contract pharma packaging capacity by 20 per cent.
Avalon Pharmaceuticals and ChemDiv have revealed details on a collaboration in which the two companies are to engage in drug discovery in the oncology sector focusing on small molecules as a basis for therapeutic development.
In a controversial move, the US Food and Drug Administration (FDA) has given the final nod of approval to pharma companies who want to add colourful pearlescent pigments to their drugs to give them that "special something."
Quintiles has announced the opening of a new biostatistics unit that it claims will help pharma firms cut the time and cost of drug development through the "adaptive design" of clinical trials.
Aegis Therapeutics has unveiled a new formulation technology employing non-toxic excipients that maintain the physical stability and physiological activity of protein and peptide therapeutics while reducing immunogenicity.